EFDID: 308460EFD: View Filing

Issuer: INNOVATE BIOPHARMACEUTICALS, INC. (0001551986) - D

Accession: 0001551986-19-000024 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001551986
  • Entity Name:
    INNOVATE BIOPHARMACEUTICALS, INC.
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Over 5 years ago
  • Address:
    8480 HONEYCUTT ROAD
    SUITE 120
    RALEIGH, NC 27615
  • Persons:
    Related Persons 6
    Sandeep Laumas
    Executive Officer, Director
    Jay Madan
    Executive Officer, Director
    Anthony Maida
    Director
    Lorin Johnson
    Director
    Saira Ramasastry
    Director
    Roy Proujansky
    Director
EDGAR: Offering Information
  • Accession Date:
    04/01/2019
  • First Sale Date:
    03/18/2019
  • Offering Amount:
    $9,741,900
  • Amount Sold:
    $9,741,900
  • Exemptions:
    Rule 506
  • Security Type(s):
  • Sales Clarification:
    Represents warrants to purchase up to 4,181,068 shares of common stock at an exercise price of $4.00 per share and up to 2,508,641 shares of common stock at an exercise price of $2.56 per share, issued to certain investors in a registered equity offering.
EFD: Current State Notices
View Notices

Notices found in EFD

Filed:CA, NJ, OK, TX
Inactive:IL, NV
EDGAR: Sales Compensation Recipient Information

There were no Sales Compensation Recipient Information associated with this Accession Number.

EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
INNOVATE BIOPHARMACEUTICALS, INC./s/ Jay MadanJay MadanChief Business Officer2019-04-01